抗癌药物。事实证明，智能武器很难设计。 - Suppr

Cancer drugs. Smart weapons prove tough to design.

作者信息

Couzin Jennifer

出版信息

Science. 2002 Oct 18;298(5593):522-5. doi: 10.1126/science.298.5593.522.

DOI:10.1126/science.298.5593.522

PMID:12386312

Abstract

摘要

相似文献

Cancer drugs. Smart weapons prove tough to design.

Science. 2002 Oct 18;298(5593):522-5. doi: 10.1126/science.298.5593.522.

Failing survival advantage in crucial trial, future of Iressa is in jeopardy.

J Natl Cancer Inst. 2005 Feb 16;97(4):249-50. doi: 10.1093/jnci/97.4.249.

Gefitinib does not increase survival in lung cancer patients.

Drug Discov Today. 2005 Mar 15;10(6):381. doi: 10.1016/S1359-6446(05)03401-X.

Using EGFR status to personalize treatment: lung cancer researchers reach a milestone.

J Natl Cancer Inst. 2009 Aug 5;101(15):1039-41. doi: 10.1093/jnci/djp243. Epub 2009 Jul 28.

The current situation: erlotinib (Tarceva) and gefitinib (Iressa) in non-small cell lung cancer.

Oncologist. 2005 Aug;10(7):467-70. doi: 10.1634/theoncologist.10-7-467.

Gefitinib for advanced or metastatic non-small cell lung cancer.

Issues Emerg Health Technol. 2004 Apr(55):1-4.

Lung cancer: looking ahead in 2004.

Clin Lung Cancer. 2004 Jan;5(4):200.

The rational basis of using novel targeted biological agents in non-small cell lung cancer.

Suppl Tumori. 2002 Jul-Aug;1(4):S31-3.

Afatinib (Gilotrif) for advanced non-small cell lung cancer.

Med Lett Drugs Ther. 2015 May 25;57(1469):e82-3.

Molecular predictors of response to epidermal growth factor receptor antagonists in non-small-cell lung cancer.

J Clin Oncol. 2007 Feb 10;25(5):587-95. doi: 10.1200/JCO.2006.07.3585.

引用本文的文献

Glutathione-Depleting Pro-Oxidant as a Selective Anticancer Therapeutic Agent.

ACS Omega. 2019 Jun 10;4(6):10070-10077. doi: 10.1021/acsomega.9b00140. eCollection 2019 Jun 30.

Targeting mitochondria in cancer therapy could provide a basis for the selective anti-cancer activity.

PLoS One. 2019 Mar 25;14(3):e0205623. doi: 10.1371/journal.pone.0205623. eCollection 2019.

Modulation of cell death in human colorectal and breast cancer cells through a manganese chelate by involving GSH with intracellular p53 status.

Mol Cell Biochem. 2017 Mar;427(1-2):35-58. doi: 10.1007/s11010-016-2896-6. Epub 2016 Dec 23.

Investigation into the distinct subcellular effects of docosahexaenoic acid loaded low-density lipoprotein nanoparticles in normal and malignant murine liver cells.

Biochim Biophys Acta. 2016 Nov;1860(11 Pt A):2363-2376. doi: 10.1016/j.bbagen.2016.07.004. Epub 2016 Jul 11.

Multi-OMICs and Genome Editing Perspectives on Liver Cancer Signaling Networks.

Biomed Res Int. 2016;2016:6186281. doi: 10.1155/2016/6186281. Epub 2016 Jun 14.

Mutation induced conformational changes in genomic DNA from cancerous K562 cells influence drug-DNA binding modes.

PLoS One. 2014 Jan 8;9(1):e84880. doi: 10.1371/journal.pone.0084880. eCollection 2014.

Targeting aberrant glutathione metabolism to eradicate human acute myelogenous leukemia cells.

J Biol Chem. 2013 Nov 22;288(47):33542-33558. doi: 10.1074/jbc.M113.511170. Epub 2013 Oct 2.

Ligand-receptor interaction between triterpenoids and the 11beta-hydroxysteroid dehydrogenase type 2 (11betaHSD2) enzyme predicts their toxic effects against tumorigenic r/m HM-SFME-1 cells.

J Biol Chem. 2011 Oct 21;286(42):36888-97. doi: 10.1074/jbc.M111.265900. Epub 2011 Aug 31.

Discovering Molecular Targets in Cancer with Multiscale Modeling.

Drug Dev Res. 2011 Feb 1;72(1):45-52. doi: 10.1002/ddr.20401.

Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?

Nat Rev Drug Discov. 2009 Jul;8(7):579-91. doi: 10.1038/nrd2803. Epub 2009 May 29.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Cancer drugs. Smart weapons prove tough to design.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献